Novavax
NVAX
141 hedge funds and large institutions have $550M invested in Novavax in 2014 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 56 increasing their positions, 41 reducing their positions, and 15 closing their positions.
80% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 15
37% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 41
9% more funds holding
Funds holding: 129 → 141 (+12)
6% less capital invested
Capital invested by funds: $588M → $550M (-$38M)
61% less call options, than puts
Call options by funds: $3.36M | Put options by funds: $8.55M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$17.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$15M |
| 3 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
+$9.69M |
| 4 |
BNP Paribas Asset Management
Paris,
France
|
+$5.49M |
| 5 |
WHI
William Harris Investors
Chicago,
Illinois
|
+$4.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$19.5M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$9.48M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$6.98M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.01M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$4.88M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
151
William Blair & Company
Chicago,
Illinois
| – | -$53K | -524 | Closed |
|
|
CAM
152
Capstone Asset Management
Houston,
Texas
| – | -$53K | -515 | Closed |
|
|
MFS
153
MSI Financial Services
Springfield,
Massachusetts
| – | -$6K | -55 | Closed |
|
|
EU
154
Emory University
Atlanta,
Georgia
| – | -$2K | -28 | Closed |
|
|
HNB
155
Huntington National Bank
Columbus,
Ohio
| – | -$1K | -12 | Closed |
|
|
WA
156
WFG Advisors
Dallas,
Texas
| – | -$1K | -8 | Closed |
|
NVAX Hedge Fund Activity: Q1 2014 in Review
141 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q1 2014, worth a combined $550M — down 6.5% from $588M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new NVAX positions and 15 closed out — a net gain of 12 holders — while 56 added to existing stakes and 41 trimmed.
The largest buyer was Wells Fargo, opening a new position worth an estimated $17.8M. The largest seller was HealthCor Management, cutting an estimated $19.5M.
- 141 institutional investors held Novavax (NVAX) as of Q1 2014, up from 129 in Q4 2013.
- Funds reported $550M of Novavax stock for Q1 2014, down 6.5% quarter-over-quarter.
- 27 funds opened new Novavax positions in Q1 2014 and 15 closed out, a net change of +12 holders.
- The largest Novavax buyer in Q1 2014 was Wells Fargo, an estimated $17.8M added.
- The largest Novavax seller in Q1 2014 was HealthCor Management, an estimated $19.5M sold.
Based on aggregated 13F filings for Q1 2014.